Suchergebnisse - "Rahier, J-F"

PubPharm (4)

1

Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis : a Real-World Belgian Cohort Study

enthalten in: Inflammatory bowel diseases | 2018

von Van de Vondel, S. | Baert, F. | Reenaers, C. | +40

2

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease : Results from the Multicenter European TEDDY Study

enthalten in: The American journal of gastroenterology | 2018

von Chaparro, M. | Verreth, A. | Lobaton, T. | +61

CommentIn: Am J Gastroenterol. 2018 Dec;113(12):1903. - PMID 29895982

3

Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD) : position document of the Belgian IBD Research & Development Group (BIRD)

enthalten in: Acta gastro-enterologica Belgica | 2015

von Vermeire, S. | Louis, E. | Dewit, O. | +9

4

Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients

enthalten in: Journal of Crohn's & colitis | 2013

von Baert, F. | Glorieus, E. | Reenaers, C. | +57

1
[1]